Home › Hidradenitis Suppurativa › California › Santa Clarita
Hidradenitis Suppurativa clinical trials in Santa Clarita, CA
4 studies for Hidradenitis Suppurativa are looking for participants at sites in and around Santa Clarita (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
RecruitingPhase 3
- Olive View UCLA Medical Center, Sylmar · 8 mi away
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
RecruitingPhase 1
- Amicis Research Center Valencia, Northridge · 11 mi away
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
RecruitingPhase 3
- Investigative Site US060, Northridge · 11 mi away
Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa
RecruitingPhase 2
- Northridge Clinical Trials - Northridge- Site Number : 8400005, Northridge · 11 mi away
About Hidradenitis Suppurativa
Hidradenitis suppurativa (HS), or acne inversa, is a chronic skin disease. It causes painful bumps in your armpits and groin. Learn about treatment.
More about Hidradenitis Suppurativa on MedlinePlus
Hidradenitis Suppurativa trials in other cities
- Boston, MA9 studies
- Tampa, FL7 studies
- Miami, FL6 studies
- New York City, NY5 studies
- Birmingham, AL5 studies
- Dallas, TX5 studies
- Phoenix, AZ5 studies
- New Orleans, LA4 studies
- Scottsdale, AZ4 studies
- Durham, NC4 studies
- Minneapolis, MN4 studies
- Philadelphia, PA4 studies
Other studies in Santa Clarita
- Obesity8 studies
- Heart Failure7 studies
- Atopic Dermatitis (Eczema)6 studies
- Type 2 Diabetes6 studies
- Overweight5 studies
- Cardiovascular Disease5 studies
- Asthma4 studies
- Arrhythmia4 studies
- Bradycardia4 studies
- Chronic Kidney Disease4 studies
- Eczema4 studies
- Kidney Failure3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.